Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
43,318
Sort by:
2022-2026 Global Immunodiagnostic Analyzers and Reagents-USA, Europe, Japan-Competitive Shares and SWOT Analysis, Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry Tests-Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 24,500.00
LeadingMarketResearch.com's new report is a seven-country strategic analysis of major business opportunities emerging in the immunodiagnostic market during the next five years. The report is available...
January 2022
2022-2026 Latin America Immunodiagnostic Analyzers and Reagents in 22 Countries—Competitive Shares and SWOT Analysis, Volume and Sales Segment Forecasts in 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry Tests-Latest Technologies and Instrumentation Pipeline, Emerging Opportunities in Suppliers
US$ 14,500.00
This new 22-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is available by section, and can be customized to specific in...
January 2022
2022-2026 Middle East Immunodiagnostic Analyzers and Reagents in 11 Countries—Competitive Shares and SWOT Analysis, Volume and Sales Segment Forecasts in 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry Tests-Latest Technologies and Instrumentation Pipeline, Emerging Opportunities in Suppliers
US$ 9,500.00
This new 11-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is available by section, and can be customized to specific in...
January 2022
2022-2026 North America Immunodiagnostic Analyzers and Reagents-USA, Canada, Mexico-Competitive Shares and SWOT Analysis, Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry Tests-Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 9,500.00
This new 3-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is available by section, and can be customized to specific inf...
January 2022
